Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

COVID-19, a novel coronavirus-related illness, has spread worldwide. Patients with apparently mild/moderate symptoms can suddenly develop severe pneumonia. Therefore, almost all COVID-19 patients require hospitalization, which can reduce limited medical resources in addition to overwhelming medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Masaya, Kinoshita, Noriko, Ide, Satoshi, Nomoto, Hidetoshi, Nakamoto, Takato, Saito, Sho, Ishikane, Masahiro, Kutsuna, Satoshi, Hayakawa, Kayoko, Hashimoto, Masao, Suzuki, Manabu, Izumi, Shinyu, Hojo, Masayuki, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Takasaki, Jin, Usami, Masahide, Kano, Toshikazu, Yanai, Hidekatsu, Nishida, Nao, Kanto, Tatsuya, Sugiyama, Haruhito, Ohmagari, Norio, Mizokami, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489253/
https://www.ncbi.nlm.nih.gov/pubmed/32941953
http://dx.doi.org/10.1016/j.gene.2020.145145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489253/
https://www.ncbi.nlm.nih.gov/pubmed/32941953
http://dx.doi.org/10.1016/j.gene.2020.145145

Ejemplares similares